For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Browse our health professional information, resources and educational activities on using new drugs.

| Title | Description | Content type | Date* |
|---|---|---|---|
| Medicine Update: the new consumer version of NPS RADAR | Medicine Update, a new publication from NPS, will review newly listed PBS medicines for a consumer audience, with a quality use of medicines focus, and will be available on-line from the NPS website. | Professional publication - NPS RADAR - Brief item | 2007-04-01 00:00:00 |
| Evaluating new drugs | Provides an overview of the principles and practices for assessing and prescribing new drugs. | Professional publication - NPS News | 2005-12-01 00:00:00 |
| NPS News 31 (INSERT): Questions to ask when assessing a new drugs and glossary of EBM terms | Provides a list of questions to ask when assessing a new drug and glossary of evidence-based medicine terms | Professional publication - NPS News | 2003-12-01 00:00:00 |
| New drugs | Practical examples of how to assess efficacy and safety of new drugs against promotional claims, as well as ways to consider affordability and patient acceptance. | Professional publication - NPS News | 2006-12-01 00:00:00 |
| Questions to ask when evaluating a new drug & Glossary | A checklist of questions to ask when assessing a new drug, and definitions of some evidence-based medicine terms which may help when reading clinical papers. | Professional publication - NPS factsheet | 2003-12-08 00:00:00 |
| NPS News 7: New drug treatments | Prescribing new drugs and managing pharmaceutical company representatives wanting to sell and patients wanting the latest treatments. Report on case study 3 (benzodiazepines). | Professional publication - NPS News | 1999-12-01 00:00:00 |
| Critical assessment of new drugs | Examines the process of critical assessment of new drugs with consideration of their adverse effects and cost effectiveness | Professional publication - NPS News | 2003-12-01 00:00:00 |
| NPS News article: Weighing up the cost-effectiveness of new drugs | Article discussing what 'cost-effectiveness' means in relation to new drugs and health. | NPS RADAR - Health Professional Publication | 2003-11-21 00:00:00 |
| What do we really know about new drugs? | Suggests a cautious approach to new drugs, given the limitations of evidence, lack of safety profiles in clinical trials and side effects seen in postmarketing surveillance. | Professional publication - NPS News | 2004-12-01 00:00:00 |
| Evaulating new drugs | Tips for GPs on how to interpret pharmaceutical company materials in order to make educated decisions about prescribing new drugs | Professional publication - NPS News | 2002-12-01 00:00:00 |


| Content type | Date | Title |
|---|---|---|
| Australian Prescriber - Article | 2005-02-01 00:00:00 | New developments in antiretroviral therapy for HIV infection |
| Australian Prescriber - Article | 2002-10-01 00:00:00 | How we write about new drugs |
| Australian Prescriber - Article | 1998-10-01 00:00:00 | When to use a new drug |
| Australian Prescriber - Editorial | 2006-02-01 00:00:00 | New drugs for old |
| Australian Prescriber - Editorial | 2004-02-01 00:00:00 | Are new drugs as good as they claim to be? |
| Australian Prescriber - Editorial | 2004-02-01 00:00:00 | Need for new drugs: a response |
| Australian Prescriber - Editorial | 2004-02-01 00:00:00 | Expensive new drugs: do we really need them ? |

Date published: 2009-09-20 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.